Page last updated: 2024-09-03

sulbactam and B. burgdorferi Infection

sulbactam has been researched along with B. burgdorferi Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eber, B; Gasser, RN; Klein, W; Pokan, R; Reisinger, EC; Seinost, G; Wendelin, I1
Berglöff, J; Eber, B; Gasser, R; Horwarth, R; Klein, W; Pokan, R; Reisinger, E; Sedaj, B; Seinost, G1

Other Studies

2 other study(ies) available for sulbactam and B. burgdorferi Infection

ArticleYear
Treatment of late Lyme borreliosis with cefoperazone and sulbactam.
    Lancet (London, England), 1995, Mar-04, Volume: 345, Issue:8949

    Topics: Adult; beta-Lactam Resistance; Borrelia burgdorferi Group; Cefoperazone; Drug Therapy, Combination; Humans; Immunoglobulin G; Lyme Disease; Male; Sulbactam

1995
Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
    Microbial drug resistance (Larchmont, N.Y.), 1995,Winter, Volume: 1, Issue:4

    Topics: beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Lyme Disease; Male; Middle Aged; Sulbactam

1995